<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-ONC-10000985</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2010-08-04</date_registration>
      <primary_sponsor>Armed Police General Hospital</primary_sponsor>
      <public_title>Umbilical cord mesenchymal stem cell transplantation for treatment of type2 diabetes</public_title>
      <acronym />
      <scientific_title>Umbilical cord mesenchymal stem cell transplantation for treatment of type2 diabetes</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2010-05-01</date_enrolment>
      <type_enrolment />
      <target_size>treatment group:25;</target_size>
      <recruitment_status>Completed</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=8553</url>
      <study_type>Observational study</study_type>
      <study_design>Before-After control</study_design>
      <phase>Post-market</phase>
      <hc_freetext>type 2 diabetes</hc_freetext>
      <i_freetext>treatment group:Umbilical cord mesenchymal stem cell transplantation;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Pei Zheng</firstname>
        <middlename />
        <lastname />
        <address>Neural stem cell transplantation Division, 69 Yongding Road, Haidian District, Beijing</address>
        <city />
        <country1 />
        <zip>100039</zip>
        <telephone>+86 010-88276849</telephone>
        <email>zhengpei126@126.com</email>
        <affiliation>Armed Police General Hospital</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Yihua An</firstname>
        <middlename />
        <lastname />
        <address>Neural stem cell transplantation Division, 69 Yongding Road, Haidian District, Beijing</address>
        <city />
        <country1 />
        <zip>100039</zip>
        <telephone>+86 010-88276849</telephone>
        <email>riveran@163.com</email>
        <affiliation />
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. the patients were between the ages of 18 and 70 years, male or female;
2. they had poor blood control with recent anti-diabetic therapies, including drugs and/or insulin injection for at least three months;
3. they had a negative result in testing for the glutamic acid decarboxylase antibody;
4. they had not been pregnant or nursing;
5. they had a fasting blood glucose (FBG) level &gt;=7.0 mmol/L and HbAc1&gt;=7%;
6. they had a good organic sufficiency, including heart, liver, kidney and lung, to receive interventional therapy.</inclusion_criteria>
      <agemin>18</agemin>
      <agemax>70</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. cancer;
2. serious heart disease or hypertension;
3. acute and chronic renal insufficiency or liver failure;
4. severe asthma or other severe respiratory insufficiency;
5. hemorrhagic disease, coagulopathy, contrast agent allergy or are being applied anticoagulant drugs;
6. congenital or acquired immunodeficiency diseases;
7. other endocrine and metabolic diseases.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E11</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Blood sugar;Glycated hemoglobin;Islet function;Inflammatory cytokines (IL-1beta, IL-6, IL-10 and TNF-alpha);</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Peripheral blood T lymphocyte subset count;C peptid;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Armed Police General Hospital</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2010-05-06</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>